The bio-pharmaceutical industry is one of the strategic emerging industries that the country has focused on during the 12th Five-Year Plan period. In recent years, the city has vigorously established a public service platform for the bio-pharmaceutical industry, accelerating the systemization of platform service functions, and boosting the rapid development of the bio-pharmaceutical industry. .
Recently, Dalian Huaxin Physical and Chemical Monitoring Center became the first public laboratory of testing technology service with the national qualification in the city's biomedical field under the policy and financial support of the Jinzhou New District. It can serve as more than 100 biomedical enterprises in the city. Provides product testing reports approved by 62 countries around the world.
Lu Zhengli, general manager of Dalian Hairong Technology Co., Ltd.: “In the past, the detection of impurities in these compounds needed to be done in Beijing or Shenyang, and the fastest was also 7 days. With this monitoring, we can come up with our results in two days. ."
In recent years, the city has established more than 20 public service platforms for biomedical industry at the national, provincial, and municipal levels. The service sector involves basic experiments, product testing, investment and financing, and other types of projects. It builds from laboratory development to pilot testing. A three-dimensional public service system for transforming achievements into engineering production research. Last year, the city's "biomedical public service platform" was awarded the "National SME Public Service Demonstration Platform" by the Ministry of Industry and Information Technology.
Zhang Jifeng, Executive Director of Dalian Double D High-tech Industry Development Co., Ltd.: “In the early stages of the project, we focused on technical services. In the middle of the project, we continued to engineer the service. When a project was transformed into industrialization, we Give it some consulting services in financing, marketing, and management."
Relying on the construction of public service platforms, in recent years, the city's biomedical companies have obtained a total of “863†national plan, a national major new drug creation project, and 14 national scientific and technological achievement awards, and have obtained more than 200 national patents. In the first half of this year, the city's biopharmaceutical enterprises above designated size achieved a total of RMB 5.8 billion in main business revenue, a year-on-year increase of nearly 30%.
Recently, Dalian Huaxin Physical and Chemical Monitoring Center became the first public laboratory of testing technology service with the national qualification in the city's biomedical field under the policy and financial support of the Jinzhou New District. It can serve as more than 100 biomedical enterprises in the city. Provides product testing reports approved by 62 countries around the world.
Lu Zhengli, general manager of Dalian Hairong Technology Co., Ltd.: “In the past, the detection of impurities in these compounds needed to be done in Beijing or Shenyang, and the fastest was also 7 days. With this monitoring, we can come up with our results in two days. ."
In recent years, the city has established more than 20 public service platforms for biomedical industry at the national, provincial, and municipal levels. The service sector involves basic experiments, product testing, investment and financing, and other types of projects. It builds from laboratory development to pilot testing. A three-dimensional public service system for transforming achievements into engineering production research. Last year, the city's "biomedical public service platform" was awarded the "National SME Public Service Demonstration Platform" by the Ministry of Industry and Information Technology.
Zhang Jifeng, Executive Director of Dalian Double D High-tech Industry Development Co., Ltd.: “In the early stages of the project, we focused on technical services. In the middle of the project, we continued to engineer the service. When a project was transformed into industrialization, we Give it some consulting services in financing, marketing, and management."
Relying on the construction of public service platforms, in recent years, the city's biomedical companies have obtained a total of “863†national plan, a national major new drug creation project, and 14 national scientific and technological achievement awards, and have obtained more than 200 national patents. In the first half of this year, the city's biopharmaceutical enterprises above designated size achieved a total of RMB 5.8 billion in main business revenue, a year-on-year increase of nearly 30%.
Potassium Methoxide CAS No.865-33-8
Potassium Methoxide Chemical & Physical Properties
Density 0.95 g/mL at 20 °C
Boiling Point 84°C
Melting Point -20°C
Molecular Formula CH3KO
Molecular Weight 70.132
Flash Point 7°C
PSA 23.06000
LogP 0.04670
Index of Refraction n20/D 1.37
Storage condition Flammables area
Stability Stable. Reacts violently with water. Moisture sensitive. Absorbs carbon dioxide from the air. Incompatible with acids, strong oxidizing agents, acid chlorides, acid anhydrides, alkali metals.
Water Solubility may decompose
Potassium Methoxide Application
Used as a condensing agent, a catalyst for producing methyl formate, a strong basic catalyst for dimethylformamide, and also used as a pharmaceutical raw material.
Potassium Methoxide,Potassium Methoxide Solution,Potassium Methoxide In Methanol,Potassium Methoxide Msds
ShanDong YingLang Chemical Co.,LTD , https://www.sdylhgtrade.com